Search details
1.
Comparison of long-term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia-positive acute lymphoblastic leukemia: A multicenter retrospective study.
Cancer
; 130(12): 2139-2149, 2024 Jun 15.
Article
in English
| MEDLINE | ID: mdl-38315517
2.
Measurable residual disease monitoring by ddPCR in the early posttransplant period complements the traditional MFC method to predict relapse after HSCT in AML/MDS: a multicenter retrospective study.
J Transl Med
; 22(1): 410, 2024 Apr 30.
Article
in English
| MEDLINE | ID: mdl-38689269
3.
Outcomes of haploidentical peripheral blood stem cell transplantation following myeloablative conditioning using two types of rabbit ATG: a propensity score-matched analysis.
Ann Hematol
; 103(4): 1353-1362, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38430226
4.
Double filtration plasmapheresis combined with rituximab for donor-specific antibody desensitization in haploidentical haematopoietic stem cell transplantation.
Br J Haematol
; 203(5): 829-839, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37621146
5.
Haploidentical transplants deliver equal outcomes to matched sibling transplants: a propensity score-matched analysis.
J Transl Med
; 21(1): 329, 2023 05 18.
Article
in English
| MEDLINE | ID: mdl-37198603
6.
Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients.
Ann Hematol
; 101(12): 2731-2741, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36318288
7.
Eltrombopag treatment promotes platelet recovery and reduces platelet transfusion for patients with post-transplantation thrombocytopenia.
Ann Hematol
; 99(11): 2679-2687, 2020 Nov.
Article
in English
| MEDLINE | ID: mdl-32519094
8.
CDK2 suppression synergizes with all-trans-retinoic acid to overcome the myeloid differentiation blockade of AML cells.
Pharmacol Res
; 151: 104545, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31740384
9.
Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms.
Am J Hematol
; 98(12): E391-E394, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37728241
10.
Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation.
Am J Hematol
; 97(2): E44-E47, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34778993
11.
Donor aKIR genes influence the risk of EBV and CMV reactivation after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation.
HLA
; 103(1): e15320, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-38081622
12.
Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation During the Omicron Wave: A Single-Center Study.
Open Forum Infect Dis
; 11(3): ofae038, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38481430
13.
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients With Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors.
Cell Transplant
; 33: 9636897231225821, 2024.
Article
in English
| MEDLINE | ID: mdl-38270130
14.
Graft CD8 T-cell-based risk system predicts survival in antithymocyte globulin-based myeloablative haploidentical peripheral blood stem cell transplantation.
Clin Transl Immunology
; 13(1): e1484, 2024.
Article
in English
| MEDLINE | ID: mdl-38223258
15.
Prognostic factors and clinical outcomes in patients with relapsed acute leukemia after allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 58(8): 863-873, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37120616
16.
Phytohemagglutinin-activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice.
Ann Hematol
; 91(11): 1803-12, 2012 Nov.
Article
in English
| MEDLINE | ID: mdl-22699803
17.
Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation.
Transplant Cell Ther
; 28(6): 331.e1-331.e10, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35231641
18.
Assessment of Patient-Specific Human Leukocyte Antigen Genomic Loss at Relapse After Antithymocyte Globulin-Based T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplant.
JAMA Netw Open
; 5(4): e226114, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-35385089
19.
Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients.
Infect Drug Resist
; 15: 6893-6905, 2022.
Article
in English
| MEDLINE | ID: mdl-36465805
20.
Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation.
J Zhejiang Univ Sci B
; 22(8): 695-700, 2021 Aug 15.
Article
in English
| MEDLINE | ID: mdl-34414703